Search Results - "Mizuma, Kanako"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
  2. 2

    GNAO1 mutation-related severe involuntary movements treated with gabapentin by Akasaka, Manami, Kamei, Atsushi, Tanifuji, Sachiko, Asami, Maya, Ito, Jun, Mizuma, Kanako, Oyama, Kotaro, Tokutomi, Tomoharu, Yamamoto, Kayono, Fukushima, Akimune, Takenouchi, Toshiki, Uehara, Tomoko, Suzuki, Hisato, Kosaki, Kenjiro

    Published in Brain & development (Tokyo. 1979) (01-04-2021)
    “…Mutations in GNAO1 typically result in neurodevelopmental disorders, including involuntary movements. They may be improved using calcium-channel modulators…”
    Get full text
    Journal Article
  3. 3

    Hypofibrinogenemia caused by adrenocorticotropic hormone for infantile spasms: A case report by Kamei, Atsushi, Araya, Nami, Akasaka, Manami, Mizuma, Kanako, Asami, Maya, Tanifuji, Sachiko, Chida, Shoichi

    Published in Brain & development (Tokyo. 1979) (01-01-2015)
    “…Abstract We report the case of a 7-month-old boy who developed hypofibrinogenemia (66.6 mg/dL; reference value, 170–405 mg/dL) during adrenocorticotropic…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    GNAO1 mutation-related severe involuntary movements treated with gabapentin by Akasaka, Manami, Kamei, Atsushi, Tanifuji, Sachiko, Asami, Maya, Ito, Jun, Mizuma, Kanako, Oyama, Kotaro, Tokutomi, Tomoharu, Yamamoto, Kayono, Fukushima, Akimune, Takenouchi, Toshiki, Uehara, Tomoko, Suzuki, Hisato, Kosaki, Kenjiro

    Published in Brain & development (01-04-2021)
    “…BACKGROUNDMutations in GNAO1 typically result in neurodevelopmental disorders, including involuntary movements. They may be improved using calcium-channel…”
    Get full text
    Report